Ganciclovir‐resistant cytomegalovirus encephalitis in a bone marrow transplant recipient
- 1 December 2002
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 4 (4) , 201-206
- https://doi.org/10.1034/j.1399-3062.2002.02005.x
Abstract
A 20-year-old patient, who received a bone marrow transplant in order to treat metachromatic leukodystrophy (MLD), succumbed to cytomegalovirus (CMV) encephalitis. After CMV viremia developed, the patient received ganciclovir, but he was switched to foscarnet when ganciclovir resistance was suspected. Foscarnet was discontinued because of concern about its potential central nervous system toxicity. Autopsy samples of brain and cerebrospinal fluid contained CMV DNA with a UL97 mutation (M460V) known to confer ganciclovir resistance. No foscarnet resistance mutations were found.Keywords
This publication has 27 references indexed in Scilit:
- Combination Antiviral Therapy for Ganciclovir‐Resistant Cytomegalovirus Infection in Solid‐Organ Transplant RecipientsClinical Infectious Diseases, 2002
- Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to GanciclovirThe Journal of Infectious Diseases, 2002
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomesBlood, 2001
- A Deletion Mutation in Region V of the Cytomegalovirus DNA Polymerase Sequence Confers Multidrug ResistanceThe Journal of Infectious Diseases, 2000
- Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant PatientsThe Journal of Molecular Diagnostics, 2000
- Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplantsThe Lancet, 2000
- Diagnosis and Clinical Management of Neurological Disorders Caused by Cytomegalovirus in Aids PatientsJournal of NeuroVirology, 1998
- FoscarnetDrugs, 1994
- Ganciclovir Susceptibilities of Cytomegalovirus (CMV) Isolates from Solid Organ Transplant Recipients with CMV Viremia after Antiviral ProphylaxisThe Journal of Infectious Diseases, 1993
- Human pharmacokinetics of the antiviral drug DHPGClinical Pharmacology & Therapeutics, 1986